Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Significant long term contract win

13 Oct 2016 07:00

RNS Number : 4017M
Crimson Tide PLC
13 October 2016
 

Crimson Tide PLC

("Crimson Tide" or the 'Company')

Significant long term contract win with large UK retailer

 

Crimson Tide ﴾TIDE﴿, the AIM‐quoted provider of mpro5 ‐ Smart Mobility as a Service, has signed its most significant long term contract with a large UK retailer. Its mpro5 service will be used to ensure store safety, cleanliness and security. This deployment follows a successfully executed pilot.

 

The contract value is worth over £1.7m of additional revenue over an initial term of 48 months, the largest gross revenue contract in the Company's history.

 

This extended roll out involves implementing the mobility platform to almost 500 stores to enable the scheduling of regular cleaning, reactive cleaning and incident capture; as well as providing dynamic audits and bespoke management dashboards.

 

Barrie Whipp, Executive Chairman of Crimson Tide, said: "This landmark contract is the largest in our history in terms of value and means that mpro5 will be present in nearly 500 more locations throughout the UK. The four-year term represents validation of the partnership we have quickly formed with this well-known retailer. The contract represents another cornerstone of our enterprise level agreement strategy, which now represents a substantial element of our contracted revenues for the coming years

Following this contract win we are accelerating other expansion plans, both in the UK and overseas. The Directors are extremely pleased with this long term contract, which is the culmination of a great deal of work by our team. We are very excited indeed about the future prospects of the Company and look forward to pushing ahead with further opportunities."

 

For further information:

Crimson Tide plc

 

Barrie Whipp/Steve Goodwin 01892 542 444

 

WH Ireland

James Joyce /James Bavister 020 7220 1666

 

Notes to editors

1. Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 ‐ Smart Mobility as a Service (SMaaS). mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces.

2. Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world‐class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money.

3. mpro5 is a platform‐agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment.

4. mpro5 not only helps people improve their day‐to‐day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMTBFTMBJBBFF
Date   Source Headline
30th Jun 202011:53 amRNSResult of AGM and Trading Update
15th Jun 202010:42 amRNSSignificant Contract Win
9th Jun 20204:06 pmRNSAnnual Report and Notice of AGM
7th May 20207:11 amRNSPreliminary Results
4th May 20204:05 pmRNSDIRECTOR RESIGNATION
1st Apr 20203:30 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSStatement regarding Coronavirus
13th Mar 20207:00 amRNSChange of Adviser
25th Feb 20208:19 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSSignificant contract wins in the rail sector
28th Jan 202010:43 amRNSHolding(s) in Company
3rd Jan 20209:17 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSSignificant long-term contract and trading update
1st Oct 20197:00 amRNSSignificant long-term contract win
27th Sep 20197:00 amRNSInterim Results
1st Jul 20197:00 amRNSDirector and Company Secretary Appointment
28th Jun 20193:02 pmRNSResult of AGM
27th Jun 20197:00 amRNSContract Wins and New Partnerships
7th Jun 20197:00 amRNSFinal Results and Notice of AGM
17th May 20197:00 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSPreliminary Announcement of Results to 31/12/18
16th Apr 20199:20 amRNSHolding(s) in Company
1st Mar 20192:56 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSContract Wins in the rail sector
29th Jan 20197:00 amRNSTrading Update
2nd Nov 20182:08 pmRNSExercise Of Options
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.